Openbookopenbook
Equity
Tristel PLC(TSNLF)
USD --+0.00%
Reward73High
Risk13Low
📊75%Data
2.4% dividend yield · Revenue growing 14% YoY
TSNLF
+0.0 · +0.00%
USD · PINK
Tristel PLC | Healthcare
Quality Compounder
Market Cap:287.59M
ℹ️
Reward Rating
73
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
13
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on TSNLF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Tristel PLC?

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

TSNLF · Verdict

Strong reward · low risk

TSNLF scores well on profitability and volatility with no major weaknesses flagged in the model.

Based on 88% data coverage

TSNLF · Verdict

What’s working & what to watch

Strengths 5

  • Profitability97/100

    14% net margin · 20% ROE

  • Volatility95/100

    Top decile vs peers

  • Balance sheet92/100

    Interest covered 33.5×

  • Cash flow91/100

    20% free-cash-flow margin

  • Growth82/100

    Rev +14.3% CAGR · earnings +88.8%

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Tristel PLC?

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 287.59M, and a P/E ratio of 31.6x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (73)

The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap287.59M
P/E Ratio31.5789
Dividend Yield2.37%
52 Week High6
52 Week Low4.9696
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding48M
No. of Employees267
IndustryMedical Instruments & Supplies
ExchangePINK
Beta0.249
CurrencyUSD · Reports in GBP
Websitetristel.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.